Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, a leader in brain interface
technology, is developing products to treat nervous system diseases and
disorders by bringing together advances in neuroscience, computer science
and engineering. Cyberkinetics' products are based on over ten years of
technology development and cutting-edge neuroscience research at leading
academic institutions such as Brown University, the Massachusetts Institute
of Technology, Emory University, and the University of Utah.
Cyberkinetics has received FDA clearance to market the NeuroPort(TM)
System, a neural monitor designed for acute inpatient applications and
labeled for temporary (less than 30 days) recording and monitoring of brain
electrical activity. The NeuroPort(TM) System can contribute to the
diagnosis and treatment of neurological conditions in patients who have
undergone craniotomy by providing neurologists and neurosurgeons a new
resource to detect, transmit and analyze neural activity.
Cyberkinetics' BrainGate(TM) System is being designed to give severely
paralyzed individuals, as well as individuals with motor impairment from a
variety of causes, a long-term, direct brain-computer interface for the
purpose of communication and control of a computer, assistive devices, and,
ultimately, limb movement.